2. Search Result
Search Result
Results for "

DSPE-PEG 2000

" in MedChemExpress (MCE) Product Catalog:

57

Inhibitors & Agonists

1

Fluorescent Dye

49

Biochemical Assay Reagents

2

Click Chemistry

11

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-142979
    DSPE-PEG 2000
    4 Publications Verification

    		 Liposome Others
    DSPE-PEG 2000 is a PEG polymer containing DSPE and amine end groups. DSPE-PEG 2000 can be used to form micelles as nanoparticles for drug delivery .
    DSPE-PEG 2000
  • HY-140739
    DSPE-PEG2000-Maleimide
    2 Publications Verification

    		 Liposome Neurological Disease Cancer
    DSPE-PEG2000-Maleimide is a phospholipid-PEG conjugate. DSPE-PEG2000-Maleimide utilizes the amphiphilicity of DSPE to insert into the lipid bilayer of liposomes or nanoparticles. DSPE-PEG2000-Maleimide covalently couples to the sulfhydryl (-SH) of ligands (such as antibodies, peptides, or proteins) via thiol-maleimide click chemistry, giving the particles targeting capabilities. DSPE-PEG2000-Maleimide can be used in the researches of breast cancer, lymphoma, and inherited retinal degeneration .
    DSPE-PEG2000-Maleimide
  • HY-172274A
    DSPE-PEG2000-APRPG

    		Liposome Cancer
    DSPE-PEG2000-APRPG is a PEG compound which composed of DSPE and a APRPG peptide. DSPE-PEG2000-APRPG can be used for drug delivery .
    DSPE-PEG2000-APRPG
  • HY-172278A
    DSPE-PEG2000-CGKRK

    		Liposome Cancer
    DSPE-PEG2000-CGKRK is a PEG compound which composed of DSPE and a cell-penetrating peptide (CGKRK). DSPE-PEG2000-CGKRK can be used for drug delivery .
    DSPE-PEG2000-CGKRK
  • HY-172681
    DSPE-PEG2000-VIP

    		Liposome Inflammation/Immunology
    DSPE-PEG2000-VIP is a PEG compound which composed of DSPE and a vasoactive intestinal peptide (VIP). DSPE-PEG2000-VIP can be used for drug delivery .
    DSPE-PEG2000-VIP
  • HY-172279A
    DSPE-PEG2000-TAT

    		Liposome Infection
    DSPE-PEG2000-TAT is a PEG compound which composed of DSPE and a cell-penetrating peptide (TAT) (HY-P0281). DSPE-PEG2000-TAT can be used for drug delivery .
    DSPE-PEG2000-TAT
  • HY-159194
    DSPE-PEG2000-Cy5.5

    		Liposome Cancer
    DSPE-PEG2000-Cy5.5 is a CY5.5 labeled DSPE-PEG 2000 for drug delivery and imaging .
    DSPE-PEG2000-Cy5.5
  • HY-172482
    DSPE-PEG2000-TAASGVRSMH

    		Liposome Cancer
    DSPE-PEG2000-TAASGVRSMH is a PEG compound which composed of DSPE and TAASGVRSMH. TAASGVRSMH has a strong affinity for the NG2 proteoglycan on the PC membrane. DSPE-PEG2000-TAASGVRSMH can be used for drug delivery .
    DSPE-PEG2000-TAASGVRSMH
  • HY-172687
    DSPE-PEG2000-CSTSMLKAC

    		Liposome Cardiovascular Disease
    DSPE-PEG2000-CSTSMLKAC is a PEG compound which composed of DSPE and a peptide (CSTSMLKAC). CSTSMLKAC is capable of mediating selective homing of phage to ischemic heart tissue. DSPE-PEG2000-CSTSMLKAC can be used for drug delivery .
    DSPE-PEG2000-CSTSMLKAC
  • HY-140739A
    DSPE-PEG2000-Maleimide free acid

    		Liposome Neurological Disease Cancer
    DSPE-PEG2000-Maleimide free acid is a phospholipid-PEG conjugate. DSPE-PEG2000-Maleimide free acid utilizes the amphiphilicity of DSPE to insert into the lipid bilayer of liposomes or nanoparticles. DSPE-PEG2000-Maleimide free acid covalently couples to the sulfhydryl (-SH) of ligands (such as antibodies, peptides, or proteins) via thiol-maleimide click chemistry, giving the particles targeting capabilities. DSPE-PEG2000-Maleimide free acid can be used in the researches of breast cancer, lymphoma, and inherited retinal degeneration .
    DSPE-PEG2000-Maleimide free acid
  • HY-172684
    DSPE-PEG2000-GRGDS

    		Liposome Others
    DSPE-PEG2000-GRGDS is a PEG compound which composed of DSPE and an anti-adhesion peptide (GRGDS). GRGDS can block the binding and adhesion of extracellular matrix to cell surface integrins. DSPE-PEG2000-GRGDS can be used for drug delivery .
    DSPE-PEG2000-GRGDS
  • HY-172503
    DSPE-PEG2000-KAA

    		Liposome Cancer
    DSPE-PEG2000-KAA is a PEG compound which composed of DSPE and a CKAAKNK peptide (KAA). KAA specifically binds to tumor vessels in RIP-Tag2 transgenic mice. DSPE-PEG2000-KAA can be used for drug delivery .
    DSPE-PEG2000-KAA
  • HY-172473
    DSPE-PEG2000-NGR

    		Liposome Cancer
    DSPE-PEG2000-NGR is a PEG compound which composed of DSPE and an Asn-Gly-Arg (NGR) peptide. NGR peptide can target tumor vascular antigen CD13. DSPE-PEG2000-NGR can be used for drug delivery .
    DSPE-PEG2000-NGR
  • HY-172497
    DSPE-PEG2000-CREKA

    		Liposome Cancer
    DSPE-PEG2000-CREKA is a PEG compound which composed of DSPE and a fibrin-targeting peptide (CREKA). CREKA peptide can be used to target tumor cells and tumor vasculature, exhibiting antitumor activity. DSPE-PEG2000-CREKA can be used for drug delivery .
    DSPE-PEG2000-CREKA
  • HY-172696
    DSPE-PEG2000-WYRGRL

    		Liposome Inflammation/Immunology
    DSPE-PEG2000-WYRGRL is a PEG compound which composed of DSPE and a cartilage-targeting peptide (WYRGRL). WYRGRL is a collagen II-targeting peptide that can bind to collagen II α1. DSPE-PEG2000-WYRGRL can be used for drug delivery .
    DSPE-PEG2000-WYRGRL
  • HY-172485
    DSPE-PEG2000-LTLRWVGLMS

    		Liposome Cancer
    DSPE-PEG2000-LTLRWVGLMS is a PEG compound which composed of DSPE and a decapeptide (LTLRWVGLMS). The chondroitin sulfate proteoglygan NG2 is a receptor for LTLRWVGLMS. LLRWVGLMS shows the homing of pericytes associated with tumor blood vessels. DSPE-PEG2000-LTLRWVGLMS can be used for drug delivery .
    DSPE-PEG2000-LTLRWVGLMS
  • HY-172275A
    DSPE-PEG2000-pPB

    		Liposome Inflammation/Immunology
    DSPE-PEG2000-pPB is a PEG compound which composed of DSPE and a cyclic oligopeptide (pPB). pPB has a strong binding affinity with PDGFRβ, which is overexpressed on activated hepatic stellate cells (HSC). DSPE-PEG2000-pPB can be used for drug delivery .
    DSPE-PEG2000-pPB
  • HY-W440823B
    DSPE-PEG2000-amine sodium

    		Liposome Cancer
    DSPE-PEG(2000)-amine is a PEGylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (HY-112530). DSPE-PEG(2000)-amine can be used in the synthesis of solid lipid and thermosensitive liposomal nanoparticles for the delivery of anticancer agents .
    DSPE-PEG2000-amine sodium
  • HY-172726
    DSPE-PEG2000-EB1

    		Liposome Cancer
    DSPE-PEG2000-EB1 is a PEG compound which composed of DSPE and pH responsive membrane-penetrating peptide (EB1). DSPE-PEG2000-EB1 can be used for drug delivery .
    DSPE-PEG2000-EB1
  • HY-172277A
    DSPE-PEG2000-R9

    		Liposome Neurological Disease
    DSPE-PEG2000-R9 is a PEG compound which composed of DSPE and a poly-arginine-9 peptide (R9). DSPE-PEG2000-R9 can be used for drug delivery .
    DSPE-PEG2000-R9
  • HY-172699
    DSPE-PEG2000-ANG

    		Liposome Cancer
    DSPE-PEG2000-ANG is a PEG compound which composed of DSPE and a dual-targeting ligand (Angiopep-2, ANG). ANG exhibits high LRP1 binding efficiency and has been used for glioma-targeting delivery. DSPE-PEG2000-ANG can be used for drug delivery .
    DSPE-PEG2000-ANG
  • HY-172708
    DSPE-PEG2000-PP1

    		Liposome Neurological Disease
    DSPE-PEG2000-PP1 is a PEG compound which composed of DSPE and a PP1 peptide. PP1 peptide targets the inflammatory atherosclerotic plaque. DSPE-PEG2000-PP1 can be used for drug delivery .
    DSPE-PEG2000-PP1
  • HY-144000A
    DSPE-PEG2000-PDP

    		Liposome Others
    DSPE-PEG2000-PDP is a phospholipid PEG conjugate that can be used in drug delivery applications .
    DSPE-PEG2000-PDP
  • HY-172464
    DSPE-PEG2000-cRGD

    		Liposome Integrin Cancer
    DSPE-PEG2000-cRGD is a PEG compound which composed of DSPE and an αvβ3 targeting peptide (cRGD). cRGD peptide can specifically bind to αvβ3 on the surface of many cancer cells and neovascular cells. DSPE-PEG2000-cRGD can be used for drug delivery .
    DSPE-PEG2000-cRGD
  • HY-172702
    DSPE-PEG2000-NYZL1

    		Liposome Cancer
    DSPE-PEG2000-NYZL1 is a PEG compound which composed of DSPE and a NYZL1 peptide. NYZL1 can specifically bind to bladder cancer tissues and cells. DSPE-PEG2000-NYZL1 can be used for drug delivery .
    DSPE-PEG2000-NYZL1
  • HY-172467
    DSPE-PEG2000-CTT2

    		Liposome Cancer
    DSPE-PEG2000-CTT2 is a PEG compound which composed of DSPE and a gelatinase inhibitor (CTT2 (CTTHWGFTLC)). CTT2 (CTTHWGFTLC) has the ability to specifically target tumors. DSPE-PEG2000-CTT2 can be used for drug delivery .
    DSPE-PEG2000-CTT2
  • HY-172470
    DSPE-PEG2000-GE11

    		Liposome EGFR Cancer
    DSPE-PEG2000-GE11 is a PEG compound which composed of DSPE and an EGFR targeting peptide (GE11). GE11 can be used for EGFR overexpressed cancer cells. DSPE-PEG2000-GE11 can be used for drug delivery .
    DSPE-PEG2000-GE11
  • HY-172476
    DSPE-PEG2000-YIGSR

    		Liposome Cancer
    DSPE-PEG2000-YIGSR is a PEG compound which composed of DSPE and a biomimetic peptide YIGSR. YIGSR interacts with the 67 kDa laminin binding protein (LBP) and promotes adhesion and spreading of a large number of cell types including endothelial cells, fibroblasts and smooth muscle cells. DSPE-PEG2000-YIGSR can be used for drug delivery .
    DSPE-PEG2000-YIGSR
  • HY-172723
    DSPE-PEG2000-T7

    		Liposome Cancer
    DSPE-PEG2000-T7 is a PEG compound which composed of DSPE and a transferrin receptor (TfR) peptide (T7). T7 (HAIYPRH) specifically binds to TfR (transferrin receptor). DSPE-PEG2000-T7 can be used for drug delivery .
    DSPE-PEG2000-T7
  • HY-168374
    DSPE-PEG(2000)-Mannose

    		Biochemical Assay Reagents Cancer
    DSPE-PEG(2000)-Mannose can be used to construct liposome vaccines to improve the anti-tumor effect of vaccines .
    DSPE-PEG(2000)-Mannose
  • HY-172494
    DSPE-PEG2000-iRGD

    		Liposome Integrin Cancer
    DSPE-PEG2000-iRGD is a PEG compound which composed of DSPE and an αv-integrins targeting peptide (iRGD). iRGD peptide binds to αv-integrins, and then proteolytically cleaved in the tumor to produce CRGDK/R to interact with neuropilin-1, and has tumor-targeting and tumor-penetrating properties. DSPE-PEG2000-iRGD can be used for drug delivery .
    DSPE-PEG2000-iRGD
  • HY-172281A
    DSPE-PEG2000-CCK8

    		Liposome Cardiovascular Disease
    DSPE-PEG2000-CCK8 is a PEG compound which composed of DSPE and a Cholecystokinin-8 (CCK8). Cholecystokinin-8 has the activity of peptide regulating gallbladder contraction and digestive system function. DSPE-PEG2000-CCK8 can be used for drug delivery .
    DSPE-PEG2000-CCK8
  • HY-172479
    DSPE-PEG2000-F3

    		Liposome Cancer
    DSPE-PEG2000-F3 is a PEG compound which composed of DSPE and a nucleolin targeting peptide (F3). F3 peptide can specifically bind to cell surface nucleolin and undergo an effective cell surface to nucleus transport. DSPE-PEG2000-F3 can be used for drug delivery .
    DSPE-PEG2000-F3
  • HY-170706
    DSPE-PEG2000-COOH

    		Liposome Cancer
    DSPE-PEG(2000)-COOH is a PEGylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (HY-112530) .
    DSPE-PEG2000-COOH
  • HY-172488
    DSPE-PEG2000-K237

    		Liposome Cancer
    DSPE-PEG2000-K237 is a PEG compound which composed of DSPE and a KDR targeting peptide (K237). K237 can functionally disrupt the interaction between VEGF and the KDR receptor and cause potent biological effects that include the inhibition of angiogenesis and tumor growth. DSPE-PEG2000-K237 can be used for drug delivery .
    DSPE-PEG2000-K237
  • HY-172690
    DSPE-PEG2000-THRPPMWSPVWP

    		Liposome Cancer
    DSPE-PEG2000-THRPPMWSPVWP is a PEG compound which composed of DSPE and a transferrin receptor (TfR) peptide (THRPPMWSPVWP). THRPPMWSPVWP binds to the TfR and is subsequently internalized into TfR-expressing cells .
    DSPE-PEG2000-THRPPMWSPVWP
  • HY-173606
    DSPE-PEG2000-Azide ammonium

    		Liposome Others
    DSPE-PEG2000-Azide ammonium is an azide containing lipid that can be used to form micelles as nanoparticles for drug delivery . DSPE-PEG2000-Azide ammonium is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
    DSPE-PEG2000-Azide ammonium
  • HY-170704
    DSPE-PEG2000-TCO

    		Liposome Metabolic Disease
    DSPE-PEG2000-TCO is a PEGylated derivative of 1,2-Distearoyl-sn-glycero-3-phosphorylethanolamine (HY-112530) that can be used to construct lipid nanoparticles (LNPs) .
    DSPE-PEG2000-TCO
  • HY-172491
    DSPE-PEG2000-ESBP

    		Liposome Cancer
    DSPE-PEG2000-ESBP is a PEG compound which composed of DSPE and a E-selectin-binding peptide (ESBP). As a tumor-targeting peptide, ESBP can specifically recognize and bind to receptors or markers on the surface of tumor cells .
    DSPE-PEG2000-ESBP
  • HY-172273A
    DSPE-PEG2000-M2pep

    		Liposome Cancer
    DSPE-PEG2000-M2pep is a PEG compound which composed of DSPE and a M2-polarized macrophages targeting peptide (M2pep). M2pep is conjugated to a proapoptotic peptide as monovalent or multivalent ligands to concentrate the toxic effect of the peptide to M2 macrophages. DSPE-PEG2000-M2pep can be used for drug delivery .
    DSPE-PEG2000-M2pep
  • HY-172500
    DSPE-PEG2000-SP94

    		Liposome Cancer
    DSPE-PEG2000-SP94 is a PEG compound which composed of DSPE and a cell-penetrating peptide (SP94). SP94 shows specific binding to hepatocellular carcinoma (HCC) cells .
    DSPE-PEG2000-SP94
  • HY-172711
    DSPE-PEG2000-R6H4

    		Liposome Cancer
    DSPE-PEG2000-R6H4 is a PEG compound which composed of DSPE and pH responsive membrane-penetrating peptide (R6H4). R6H4 can be used for pH responsive anticancer drug delivery purposes. DSPE-PEG2000-R6H4 can be used for drug delivery .
    DSPE-PEG2000-R6H4
  • HY-172693
    DSPE-PEG2000-TH

    		Liposome Cancer
    DSPE-PEG2000-TH is a PEG compound which composed of DSPE and a pH-responsive cell penetrating peptide (TH). TH is activated in an acidic environment (such as the tumor microenvironment) and can selectively carry small molecules, oligonucleotides, proteins, etc. into tumor cells .
    DSPE-PEG2000-TH
  • HY-172276A
    DSPE-PEG2000-R8

    		Liposome Cancer
    DSPE-PEG2000-R8 is a PEG compound which composed of DSPE and a cell-penetrating peptide (R8). pDSPE-PEG2000-R8 can be used for drug delivery .
    DSPE-PEG2000-R8
  • HY-172271A
    DSPE-PEG2000-LyP-1

    		Liposome Cancer
    DSPE-PEG2000-LyP-1 is a PEG compound which composed of DSPE and a nine residue peptide (LyP-1) (HY-P2526). LyP-1 targets tumor-associated lymphatic vessels and macrophages .
    DSPE-PEG2000-LyP-1
  • HY-172280A
    DSPE-PEG2000-octreotide

    		Liposome Cancer
    DSPE-PEG21000-Octreotide is a PEG compound which composed of DSPE and a Octreotide (HY-P0036). Octreotide is a somatostatin receptor agonist. Octreotide has antitumor activity, mediates apoptosis and may also be used in disease studies in acromegaly. DSPE-PEG2000-Octreotide can be used for drug delivery .
    DSPE-PEG2000-octreotide
  • HY-172705
    DSPE-PEG2000-RVG29

    		Liposome nAChR Cancer
    DSPE-PEG2000-RVG29 is a PEG compound which composed of DSPE and a Rabies virus glycoprotein 29 (RVG29). RVG29 can bind specifically to the nicotinic acetylcholine receptor (nAChR) at the blood-brain barrier (BBB) and cross over the BBB .
    DSPE-PEG2000-RVG29
  • HY-172714
    DSPE-PEG2000-MPG

    		Liposome Infection
    DSPE-PEG2000-MPG is a PEG compound which composed of DSPE and a peptide vector (MPG). MPG is derived from both the nuclear localisation sequence (NLS) of SV40 large T antigen and the fusion peptide domain of HIV-1 gp41. MPG could deliver short oligonucleotides into cells efficiently and independently of the endosomal pathway .
    DSPE-PEG2000-MPG
  • HY-172272A
    DSPE-PEG2000-A7R

    		Liposome VEGFR Cancer
    DSPE-PEG2000-A7R is a PEG compound which composed of DSPE and a tumor vascular targeting peptide (A7R). A7R exhibits high affinity and specificity for VEGFR-2, which is overexpressed in various tumors .
    DSPE-PEG2000-A7R
  • HY-W440888
    DSPE-PEG-Folate, MW 2000

    DSPE-PEG(2000) Folate

    		 Liposome Others
    DSPE-PEG-Folate, MW 2000 is a PEG derivative containing folic acid. DSPE-PEG-Folate, MW 2000 has a targeting effect and bind to folate receptors in cancer cells. DSPE-PEG-Folate, MW 2000 form micelles/lipid bilayer and can be used to targeted drug delivery system research.
    DSPE-PEG-Folate, MW 2000

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: